Background: Subdural hematoma (SDH) is associated with a high mortality rate. The risk of SDH in cirrhotic patients has not been well studied. Aim: The aim of the study was to examine the risk of SDH in cirrhotic patients. Design: A retrospective study from a universal insurance claims database of Taiwan. Methods: A cohort of 9455 liver cirrhotic patients from 2000 to 2011 and an age-and sex-matched control cohort of 35992 subjects without cirrhosis were identified. The severity of liver cirrhosis was classified into uncomplicated and complicated according to presence of complications or not. The incidence and hazard ratio of SDH were measured by the end of 2011. Results: The mean follow-up years were 4.34 6 3.45 years in the cirrhosis cohort and 6.36 6 3.28 years in the non-cirrhosis cohort. The incidence of SDH was 2.73-fold higher in the cirrhosis cohort than in the control cohort (29.3 vs. 10.9 per 10 000 person-years), with an adjusted hazard ratio of 2.73 (95% CI ¼ 2.19-3.42), 2.42 (95% CI ¼ 1.89-3.08), and 5.07 (95% CI ¼ 3.38-7.60) in the all liver cirrhosis, the uncomplicated liver cirrhosis, and the complicated liver cirrhosis patients compared to the control cohort. The adjusted hazard ratios were 2.65 (95% CI ¼ 2.06-3.41) for traumatic SDH and 3.09 (95% CI 1.91-5.02) for non-traumatic SDH in liver cirrhosis patients, compared to the controls. Conclusions: This study demonstrates that patients with cirrhosis are at higher risk of both traumatic and non-traumatic SDH than individuals without cirrhosis. The risk increases further in patients with complicated liver cirrhosis.
Introduction
Subdural hematoma (SDH) is the most common traumatic brain injury with high fatality rate. 1, 2 The disease is usually caused by tears in bridging veins crossing the subdural space, resulting in blood gathering between the dura mater and the brain. 3 Arterial rupture can also lead to SDH, and this source accounts for approximately 20-30% of SDH cases. 4 SDH may cause an increase in intracranial pressure, leading to compression of and damage to brain tissue. Clinical presentations of SDH are classified into acute, subacute and chronic. Patients with acute SDH often have a major trauma, most commonly caused by motor vehicle crashes in younger patients and by falls in elderly patients. 3, 5 Chronic SDH develop over a period of days to weeks, often occurring in elderly patients after a minor head injury or fall, though such a cause is not identifiable in 50% of patients. [6] [7] [8] Patients with significant cerebral atrophy are at high risk for SDH. This population includes those with advancing age, chronic alcohol abuse, and previous traumatic brain injury. 9 Other risk factors include use of anticoagulants or antiplatelet drugs, bleeding diatheses, reduced cognitive function, epilepsy, low intracranial pressure and hemodialysis. 6, 10, 11 Cirrhosis is a global serious health problem with high morbidity and mortality. It accounted for approximately 49 500 deaths in the United States in 2010. 12 Patients with cirrhosis frequently have low platelet counts and elevated international normalized ratios, which lead to bleeding tendency. 13 Brain atrophy has been observed in cirrhotic patients. 14 Cognitive disturbances associated with cirrhosis can increase the risk for falls. 15 However, no study has investigated whether cirrhotic patients are at a higher risk of SDH. This study was designed to compare the risk of both acute/subacute and chronic SDH between cirrhotic patients and noncirrhotic controls using a population-based universal insurance claims database from Taiwan.
Materials and methods

Data source
We conducted this study using the Database from the National Health Insurance program of Taiwan, which was initiated in 1995 to provide coverage of approximately 99% of the entire 23 million population of Taiwan. The diagnostic codes in this database were based on the International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM). To assure the accuracy of diagnosis, the Bureau of National Health Insurance sifted and validated medical records. Because patient identifications were scrambled into surrogate numbers to protect patient privacy, no patient's consent was required for this study. This study has been approved by the Research Ethics Committee at China Medical University Hospital (CMUH104-REC2-115).
Study participants
We identified patients who were 20 years of age or older with newly diagnosed liver cirrhosis (ICD-9-CM codes 571. 
Statistical analysis
Variables were compared using the Chi-square test for categorical variables. An independent t-test was used to compare continuous variables. We estimated the cumulative incidence of subsequent SDH in the liver cirrhosis and the control cohort by using the Kaplan-Meier method, and the differences were evaluated using a log-rank test. The incidences of SDH in the liver cirrhosis and the control cohorts were calculated by dividing the total number of SDH events by the total follow-up period (per 10 000 person-years). Univariate and multivariaate Cox proportional hazards regression analysis were used to estimate the hazard ratio (HR) and 95% confidence intervals (CI) of developing SDH. We further used Cox models to measure relative HRs of the liver cirrhosis cohort compared to the control cohort for SDH by age, gender, comorbidity and medication use. All statistical analyses were performed using SAS 9.4 statistical software (SAS Institute, Inc., Cary, NC). The significance level for all analyses was set as a P values of 0.05.
Results
Eligible study participants consisted of 9455 patients in the liver cirrhosis cohort and 35 992 persons in the control cohort, with similar age and sex distributions (Table 1 ). In the liver cirrhosis and the control cohorts, 33.9% patients aged 50-64 years, and 69.3% of the patients were men. The mean ages in the liver cirrhosis cohort and the control cohort were 57.3 and 56.7 years, respectively. Liver cirrhotic patients were more prevalent with coronary artery disease, congestive heart failure, stroke, hyperlipidemia, atrial fibrillation, hypertension, diabetes, cancer, ESRD and usage of aspirin, clopidogrel, and warfarin (all P < 0.05) than the control cohort. The mean follow-up time for SDH events was shorter in the liver cirrhosis cohort than in the control cohort (4.34 6 3.45 and 6.36 6 3.28 years, respectively). The Kaplan-Meier graph ( Fig. 1) shows that the cumulative incidence of SDH was higher for the liver cirrhosis cohort than for the control cohort (log-rank test P < 0.001).
The overall incidence densities of SDH were 10.9, 29.3, 26.7 and 43.4 per 10 000 person-years in the control, the all liver cirrhosis, the uncomplicated liver cirrhosis, and the complicated liver cirrhosis cohorts, respectively ( Table 2 ). The corresponding adjusted HRs of the SDH were 2.73 (95% CI ¼ 2.19-3.42), 2.42 (95% CI ¼ 1.89-3.08), and 5.07 (95% CI ¼ 3.38-7.60) for the all liver cirrhosis, the uncomplicated liver cirrhosis and the complicated liver cirrhosis cohorts, compared to the control cohort, respectively, after adjusting for age, gender and comorbidity of dementia, coronary artery disease, congestive heart failure, stroke, atrial fibrillation, hypertension, diabetes, cancer, and ESRD, use of aspirin, clopidogrel and warfarin. Compared with patients aged 20-49 years old, the risk of SDH was 1.73-fold higher in those aged 50-64 years (95% CI ¼ 1.26-2.36), and 3.96-fold higher in those aged ! 65 years (95% CI ¼ 2.89-5.42). The adjusted HR of SDH was The incidence of traumatic SDH incidence was higher than that of non-traumatic SDH incidence in both cohorts ( Table 3) . The adjusted HR for the liver cirrhosis cohort compared to the control cohort was higher for both non-traumatic SDH (adjusted HR ¼ 3.09, 95% CI ¼ 1.91-5.02) and traumatic SDH (adjusted HR ¼ 2.65, 95% CI ¼ 2.06-3.41). The SDH incidence was higher with advancing age, in men than in women, and increased with the presence of comorbidity, and with medication use. The adjusted HR of SDH was significant for most stratification among the liver cirrhosis cohort compared to the control cohort.
Discussion
Our study demonstrated that cirrhotic patients were more likely than non-cirrhotic subjects to develop SDH. There are some case reports about SDH as a complication in patients with liver cirrhosis. 16, 17 However, studies on the risk of SDH in cirrhotic patients have been few. Subjects with complicated cirrhosis had a significant higher hazard of SDH compared with those without complications (adjusted HR 5.07 vs. 2.42), indicating that the SDH risk increased with the severity of cirrhosis. No previous studies have reported these above findings. These findings strengthened the possible causal relationship between cirrhosis and the risk of SDH. Several factors may explain the increased risk of SDH in association with cirrhosis. Coagulation factor defects contributes to bleeding tendency in cirrhosis patients. The liver is the site of production of coagulation factors including factors I, II, V, VII, IX, X, and XI. 18 Thrombocytopenia, platelet dysfunction, and hyperfibrinolysis, often observed in liver disease, may also related to bleeding diathesis in patients with cirrhosis. 19, 20 Moreover, in cirrhotic patients, particularly those are alcohol abuser, vitamin K deficiency can further exacerbate deficiencies of vitamin K-dependent factors and lead to improper modifications. 21 In addition, diffuse brain atrophy has been observed in cirrhotic patients, especially those with overt hepatic encephalopathy. 22, 23 Patients with alcoholic cirrhosis were more likely than non-alcoholic cirrhotic patients to develop brain atrophy. 24 The increased length of bridging veins makes these patients vulnerable to SDH. Fall has also been related to an increased risk of traumatic SDH. Hepatic encephalopathy, decreased muscle mass, gross ascites, alcoholic use, and comorbidities are factors that have been found to increase susceptibility to vehicle accidents and a higher risk of falls in cirrhotic patients. [25] [26] [27] [28] [29] Cognitive dysfunction in patients with cirrhosis, which also leads to falls, does not result from hepatic encephalopathy alone. Indeed, it is frequently multifactorial, due to the contribution of other conditions, such as malnutrition, alcohol, hepatitis C virus infection, diabetes or treatment with psychoactive drugs. 15 The strength of the present study includes a large populationbased sample size and a matched cohort study model in design. However, there are several limitations. First, information on education level, lifestyle, body mass index and laboratory data are unavailable from the database. Therefore these variables could not be adjusted in the data analysis. Secondly, because the findings of neuroimaging studies are also not available from this database, it was not possible to classify SDH into acute or chronic. Furthermore, SDH and other comorbidities were identified using Adjusted for age, gender, and comorbidity of dementia, coronary artery disease, congestive heart failure, stroke, atrial fibrillation, hypertension, diabetes, cancer, ESRD, and use of aspirin, clopidogrel and warfarin.
*P < 0.05, **P < 0.01, ***P < 0.001.
ICD-9-CM codes. The validity of diagnostic codes for SDH could not be calculated. However, the diagnostic codes of this database has been validated. 30 
Conclusion
In conclusion, this study shows that patients with cirrhosis are at increased risk of both traumatic and non-traumatic SDH. The risk increases further in patients with complicated liver cirrhosis. Because of the devastating consequences, appropriate prevention such as cautious use of anticoagulants and fall prevention is necessary for cirrhotic patients. When cirrhotic patients presented with head injury or consciousness disturbance, SDH should be kept in mind as one of the differential diagnoses. Subjects with any comorbidity of dementia, coronary artery disease, congestive heart failure, stroke, hyperlipidemia, atrial fibrillation, hypertension, diabetes, cancer and ESRD were classified into the presence of the comorbidity group. *P < 0.05, **P < 0.01, ***P < 0.001.
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